Response to Comments on Maddaloni et al. Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care 2025;48:235-242

Scritto il 21/03/2025
da Ernesto Maddaloni

No abstract

Diabetes Care. 2025 Apr 1;48(4):e61-e62. doi: 10.2337/dci24-0109.

NO ABSTRACT

PMID:40117475 | DOI:10.2337/dci24-0109